In this study, we set out to substantiate the hypothesis that a subset of lymphomas that are initially classified as FL without BCL2 translocation (translocation-negative FL), actually represent NMZL. The gene discussed is BCL2; the disease is nodal marginal zone B-cell lymphoma.